Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

Conditions: Critical Limb Ischemia Interventions: Drug: EPCs; Behavioral: Clinical standard treatment (CST) Sponsors: Allife Medical Science and Technology Co., Ltd.; First Affiliated Hospital Xi ' an Jiaotong University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials